Thanks Ashish M. Kamat, MD, MBBS for an amazing IBCG 2nd #IBCG24 Honored to to co-chair w/Roger Li Patrick Hensley, MD Loved the discussions from 🌎experts including pt. advocates. Wes Kassouf Sia Daneshmand, M.D. Philippe spiess Andrea Necchi Jonathan Rosenberg MD Karima Oualla, MD,MSc Petros Grivas

#IBCG24 Retreat, the IBCG continues to lead the way in addressing global educational needs and learning gaps in order to improve care for people affected by #bladdercancer around the 🌎 All through proactive and dedicated global collaboration. A big thank you to

Amir is being modest, as always Horowitz Lab @Icahn School of Medicine Mount Sinai lab work will be instrumental in propelling the field of BCG immunology forward exponentially

Team Europe at #IBCG24 rocked! Many thanks for coming to cool, dry Houston this weekend. 😉

Congrats to Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Shilpa Gupta for organizing a phenomenal IBCG 2024 meeting at Houston. It was nice to catch up with friends from around the 🌎 and grateful for the opportunity to contribute to discussions to improve #bladdercancer care!

⚡️ On European Urology - Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection #BladderCancer Ashish M. Kamat, MD, MBBS sciencedirect.com/science/articl…

Really important and been saying this for many years so good to see other sources supporting. Extent of debulking prognostic but not therapeutic nor practiced in other cancers. Pts in BC2001 with biopsy only did no differently to those with resections

🚀 Exciting Opportunity! MD Anderson Cancer Center is seeking a visionary leader to chair the Genitourinary Radiation Oncology department. Lead a team driving innovation with cutting-edge technologies & advance the future of cancer care. Apply here by Sept 15! jobs.mdanderson.org/search/jobdeta…

Bowling for Bladder Cancer 🇺🇸 🇨🇦 🇬🇧 🇮🇹 🇳🇱 🇩🇪 🇦🇺 🇮🇳 🇲🇦 🇬🇷 🇨🇱 #IBCG24 IBCG #BladderCancer

This is a major announcement! Congratulations Tom Powles and team, and especially patients everywhere World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network IBCG

Perhaps in the UK system, it could expedite time to treatment. However, we need clear evidence that routine MRI improves outcomes and is cost-effective

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma. What is most important to patients regarding their experiences of disease burden and treatment #BladderCancer ⁦Nicholas Simon⁩ link.springer.com/article/10.100…

Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG) sciencedirect.com/science/articl… European Urology Oncology IBCG

Thank you for your kind words! It was truly a pleasure to have you at #IBCG24 Buon viaggio to Italy y disfruta mucho en Mexico City—¡te lo mereces! 😉

The Far-Reaching Ripple Effects of a Discredited Cancer Study Salzber stated “near-perfect association between microbes and cancer types reported in the study is, simply put, a fiction.”  #microbiome #cancer wsj.com/health/healthc…

Managing variant histology in high-risk non-muscle invasive #BladderCancer. Cookson, Michael University of Oklahoma Urology & Paolo Gontero MolinetteUrology discuss with Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center as part of the IBCG #BladderCancerForum > bit.ly/3xyeyRr

Guidelines aim to harmonize and optimize urothelial carcinoma clinical trials. Ashish M. Kamat, MD, MBBS and Matt Galsky join Sam S. Chang MD, MBA to discuss new trial parameters and the urgent need for detailed guidelines due to the dynamic landscape of treatment > bit.ly/4bcYVxh

Understanding BCG unresponsive #NMIBC: Patient perspectives, treatment options, and clinical guidance. Tom Jayram Urology Associates joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss the complexities of BCG unresponsiveness in bladder cancer treatment. #WatchNow > bit.ly/3y0qKdp

Ashish M. Kamat, MD, MBBS and Shilpa Gupta discuss the best of #ASCO24 in advanced #BladderCancer. Highlights include: improved outcomes in lymph node-only metastatic disease in #CheckMate-901, enhanced survival and QoL with EV + pembro in EV-302, and #KEYNOTE-361 > bit.ly/3MxzRWU

Congratulations Enrique!